Page last updated: 2024-10-25

cyclopentolate and Migraine Disorders

cyclopentolate has been researched along with Migraine Disorders in 1 studies

Cyclopentolate: A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.
cyclopentolate : A carboxylic ester resulting from the formal condensation of (1-hydroxycyclopentyl)(phenyl)acetic acid with N,N-dimethylethanolamine. A tertiary amine antimuscarinic with actions similar to atropine, it is used as its hydrochloride salt to produce mydriasis (excessive dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) for opthalmic diagnostic procedures. It acts more quickly than atropine and has a shorter duration of action.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Llovet-Rausell, A1
Ruiz Tolosa, F1
Kudsieh, B1

Other Studies

1 other study available for cyclopentolate and Migraine Disorders

ArticleYear
Severe ocular side effects with acetazolamide: case report.
    Archivos de la Sociedad Espanola de Oftalmologia, 2016, Volume: 91, Issue:11

    Topics: Acetazolamide; Acute Disease; Adult; Brimonidine Tartrate; Cyclopentolate; Drug Therapy, Combination

2016